Logo image of SAM

BOSTON BEER COMPANY INC-A (SAM) Stock Fundamental Analysis

NYSE:SAM - New York Stock Exchange, Inc. - US1005571070 - Common Stock

252.43  -0.31 (-0.12%)

After market: 252.43 0 (0%)

Fundamental Rating

5

Taking everything into account, SAM scores 5 out of 10 in our fundamental rating. SAM was compared to 31 industry peers in the Beverages industry. No worries on liquidiy or solvency for SAM as it has an excellent financial health rating, but there are worries on the profitability. SAM is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

SAM had positive earnings in the past year.
SAM had a positive operating cash flow in the past year.
Each year in the past 5 years SAM has been profitable.
SAM had a positive operating cash flow in each of the past 5 years.
SAM Yearly Net Income VS EBIT VS OCF VS FCFSAM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M

1.2 Ratios

SAM has a Return On Assets (5.81%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 7.92%, SAM is doing worse than 64.29% of the companies in the same industry.
SAM's Return On Invested Capital of 9.85% is in line compared to the rest of the industry. SAM outperforms 53.57% of its industry peers.
SAM had an Average Return On Invested Capital over the past 3 years of 6.09%. This is significantly below the industry average of 13.61%.
The 3 year average ROIC (6.09%) for SAM is below the current ROIC(9.85%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.81%
ROE 7.92%
ROIC 9.85%
ROA(3y)3.71%
ROA(5y)7.06%
ROE(3y)4.95%
ROE(5y)9.92%
ROIC(3y)6.09%
ROIC(5y)9.33%
SAM Yearly ROA, ROE, ROICSAM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20

1.3 Margins

SAM's Profit Margin of 4.01% is on the low side compared to the rest of the industry. SAM is outperformed by 67.86% of its industry peers.
SAM's Profit Margin has declined in the last couple of years.
SAM has a worse Operating Margin (7.68%) than 67.86% of its industry peers.
In the last couple of years the Operating Margin of SAM has declined.
SAM has a worse Gross Margin (43.95%) than 60.71% of its industry peers.
In the last couple of years the Gross Margin of SAM has declined.
Industry RankSector Rank
OM 7.68%
PM (TTM) 4.01%
GM 43.95%
OM growth 3Y-25.71%
OM growth 5Y-12.33%
PM growth 3Y-29.83%
PM growth 5Y-16.26%
GM growth 3Y-3.61%
GM growth 5Y-3.78%
SAM Yearly Profit, Operating, Gross MarginsSAM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30 40 50

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SAM is creating some value.
SAM has less shares outstanding than it did 1 year ago.
The number of shares outstanding for SAM has been increased compared to 5 years ago.
The debt/assets ratio for SAM is higher compared to a year ago.
SAM Yearly Shares OutstandingSAM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
SAM Yearly Total Debt VS Total AssetsSAM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B

2.2 Solvency

An Altman-Z score of 7.13 indicates that SAM is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 7.13, SAM belongs to the best of the industry, outperforming 82.14% of the companies in the same industry.
There is no outstanding debt for SAM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 7.13
ROIC/WACC1.06
WACC9.25%
SAM Yearly LT Debt VS Equity VS FCFSAM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M 1B

2.3 Liquidity

SAM has a Current Ratio of 2.03. This indicates that SAM is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of SAM (2.03) is better than 60.71% of its industry peers.
SAM has a Quick Ratio of 1.42. This is a normal value and indicates that SAM is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of SAM (1.42) is better than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.03
Quick Ratio 1.42
SAM Yearly Current Assets VS Current LiabilitesSAM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

SAM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.43%, which is quite impressive.
Measured over the past years, SAM shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.99% on average per year.
Looking at the last year, SAM shows a decrease in Revenue. The Revenue has decreased by -2.81% in the last year.
Measured over the past years, SAM shows a quite strong growth in Revenue. The Revenue has been growing by 15.07% on average per year.
EPS 1Y (TTM)37.43%
EPS 3Y-26.52%
EPS 5Y-3.99%
EPS Q2Q%44.59%
Revenue 1Y (TTM)-2.81%
Revenue growth 3Y4.97%
Revenue growth 5Y15.07%
Sales Q2Q%0.64%

3.2 Future

The Earnings Per Share is expected to grow by 26.10% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 2.64% on average over the next years.
EPS Next Y48.31%
EPS Next 2Y38.98%
EPS Next 3Y32.82%
EPS Next 5Y26.1%
Revenue Next Year-1.27%
Revenue Next 2Y0.56%
Revenue Next 3Y1.59%
Revenue Next 5Y2.64%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SAM Yearly Revenue VS EstimatesSAM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B 2.5B
SAM Yearly EPS VS EstimatesSAM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10 20 30 40

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 27.17 indicates a quite expensive valuation of SAM.
SAM's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of SAM to the average of the S&P500 Index (27.94), we can say SAM is valued inline with the index average.
SAM is valuated rather expensively with a Price/Forward Earnings ratio of 21.08.
SAM's Price/Forward Earnings is on the same level as the industry average.
SAM is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 24.11, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 27.17
Fwd PE 21.08
SAM Price Earnings VS Forward Price EarningsSAM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

75.00% of the companies in the same industry are more expensive than SAM, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SAM indicates a rather cheap valuation: SAM is cheaper than 89.29% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 16.88
EV/EBITDA 10.73
SAM Per share dataSAM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SAM's earnings are expected to grow with 32.82% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.56
PEG (5Y)N/A
EPS Next 2Y38.98%
EPS Next 3Y32.82%

0

5. Dividend

5.1 Amount

SAM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BOSTON BEER COMPANY INC-A

NYSE:SAM (1/17/2025, 8:25:59 PM)

After market: 252.43 0 (0%)

252.43

-0.31 (-0.12%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)10-24 2024-10-24/amc
Earnings (Next)02-12 2025-02-12/amc
Inst Owners74.89%
Inst Owner Change-0.45%
Ins Owners7.28%
Ins Owner Change0.45%
Market Cap2.90B
Analysts54.78
Price Target317.78 (25.89%)
Short Float %3.82%
Short Ratio2.78
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.48%
Min EPS beat(2)-13.33%
Max EPS beat(2)6.37%
EPS beat(4)2
Avg EPS beat(4)2882.67%
Min EPS beat(4)-480.23%
Max EPS beat(4)12017.9%
EPS beat(8)3
Avg EPS beat(8)1398.56%
EPS beat(12)3
Avg EPS beat(12)918.21%
EPS beat(16)4
Avg EPS beat(16)683.88%
Revenue beat(2)0
Avg Revenue beat(2)-2.14%
Min Revenue beat(2)-4.01%
Max Revenue beat(2)-0.26%
Revenue beat(4)1
Avg Revenue beat(4)-1.99%
Min Revenue beat(4)-5.79%
Max Revenue beat(4)2.09%
Revenue beat(8)4
Avg Revenue beat(8)0.49%
Revenue beat(12)6
Avg Revenue beat(12)-0.04%
Revenue beat(16)9
Avg Revenue beat(16)0.54%
PT rev (1m)2.59%
PT rev (3m)1.94%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-58.5%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.73%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.19%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-0.83%
Valuation
Industry RankSector Rank
PE 27.17
Fwd PE 21.08
P/S 1.45
P/FCF 16.88
P/OCF 12.09
P/B 2.86
P/tB 3.28
EV/EBITDA 10.73
EPS(TTM)9.29
EY3.68%
EPS(NY)11.98
Fwd EY4.74%
FCF(TTM)14.96
FCFY5.92%
OCF(TTM)20.88
OCFY8.27%
SpS174.59
BVpS88.34
TBVpS77.07
PEG (NY)0.56
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.81%
ROE 7.92%
ROCE 13.76%
ROIC 9.85%
ROICexc 12.77%
ROICexgc 15.02%
OM 7.68%
PM (TTM) 4.01%
GM 43.95%
FCFM 8.57%
ROA(3y)3.71%
ROA(5y)7.06%
ROE(3y)4.95%
ROE(5y)9.92%
ROIC(3y)6.09%
ROIC(5y)9.33%
ROICexc(3y)7.34%
ROICexc(5y)10.74%
ROICexgc(3y)9.03%
ROICexgc(5y)13.76%
ROCE(3y)8.5%
ROCE(5y)13.03%
ROICexcg growth 3Y-21.89%
ROICexcg growth 5Y-10.38%
ROICexc growth 3Y-20.67%
ROICexc growth 5Y-13.91%
OM growth 3Y-25.71%
OM growth 5Y-12.33%
PM growth 3Y-29.83%
PM growth 5Y-16.26%
GM growth 3Y-3.61%
GM growth 5Y-3.78%
F-Score8
Asset Turnover1.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 73.62%
Cap/Sales 3.4%
Interest Coverage 250
Cash Conversion 97.32%
Profit Quality 213.73%
Current Ratio 2.03
Quick Ratio 1.42
Altman-Z 7.13
F-Score8
WACC9.25%
ROIC/WACC1.06
Cap/Depr(3y)129.74%
Cap/Depr(5y)153.57%
Cap/Sales(3y)4.9%
Cap/Sales(5y)6.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.43%
EPS 3Y-26.52%
EPS 5Y-3.99%
EPS Q2Q%44.59%
EPS Next Y48.31%
EPS Next 2Y38.98%
EPS Next 3Y32.82%
EPS Next 5Y26.1%
Revenue 1Y (TTM)-2.81%
Revenue growth 3Y4.97%
Revenue growth 5Y15.07%
Sales Q2Q%0.64%
Revenue Next Year-1.27%
Revenue Next 2Y0.56%
Revenue Next 3Y1.59%
Revenue Next 5Y2.64%
EBIT growth 1Y17.47%
EBIT growth 3Y-22.02%
EBIT growth 5Y0.88%
EBIT Next Year88.36%
EBIT Next 3Y33.62%
EBIT Next 5Y27.33%
FCF growth 1Y29.09%
FCF growth 3Y21.03%
FCF growth 5Y13.26%
OCF growth 1Y4.1%
OCF growth 3Y1.52%
OCF growth 5Y10.17%